Short C D, Durrington P N, Mallick N P, Hunt L P, Tetlow L, Ishola M
Kidney Int. 1986 Jun;29(6):1224-8. doi: 10.1038/ki.1986.131.
The serum lipoprotein concentrations, including high-density lipoprotein (HDL) subfractions and apolipoproteins Al and B were measured in 21 patients (14 male and seven female) with nephrotic range proteinuria (greater than 3g/24hr), well maintained renal function (creatinine clearance greater than 35 mliter/min/1.73m2) and biopsy-proven primary glomerular disease. In these, and in a further five patients (creatinine clearance greater than 15 mliter/min/1.73m2), urinary apolipoprotein Al output was determined. Total HDL cholesterol was similar in patients and controls, but in male patients, HDL2 was low (0.54 +/- 0.10 mmole/liter, mean +/- SEM) compared to controls (0.75 +/- 0.04 mmole/liter, P less than HDL3 was high (0.81 +/- 0.07 in patients and 0.63 +/- 0.02 mmole/liter in controls, P less than 0.01). In women, there was a similar tendency for HDL2 to be lower in patients (0.68 +/- 0.18 mmole/liter) than in controls (0.85 +/- 0.10 mmole/liter). Multiple regression analysis revealed that major determinants of the urinary apolipoprotein Al output were the urinary protein output and selectivity index (multiple r = 0.85). Furthermore, some patients lost apolipoprotein Al into their urine at rates indicating increased production of apolipoprotein Al in the nephrotic syndrome. The serum HDL subfraction concentrations in the nephrotic syndrome could be explained by a combination of increased HDL production and increased urinary loss of low molecular wt HDL.
对21例肾病范围蛋白尿(大于3g/24小时)、肾功能良好(肌酐清除率大于35ml/min/1.73m²)且经活检证实为原发性肾小球疾病的患者(14例男性和7例女性),检测了血清脂蛋白浓度,包括高密度脂蛋白(HDL)亚组分以及载脂蛋白A1和B。对这些患者以及另外5例患者(肌酐清除率大于15ml/min/1.73m²)测定了尿载脂蛋白A1排泄量。患者组和对照组的总HDL胆固醇相似,但男性患者的HDL2较低(0.54±0.10mmol/L,均值±标准误),而对照组为(0.75±0.04mmol/L,P<0.01);HDL3较高(患者组为0.81±0.07,对照组为0.63±0.02mmol/L,P<0.01)。女性患者中也有类似趋势,即患者组的HDL2(0.68±0.18mmol/L)低于对照组(0.85±0.10mmol/L)。多元回归分析显示,尿载脂蛋白A1排泄量的主要决定因素是尿蛋白排泄量和选择性指数(复相关系数r = 0.85)。此外,一些患者尿载脂蛋白A1的丢失率表明肾病综合征中载脂蛋白A1的生成增加。肾病综合征中血清HDL亚组分浓度的变化可由HDL生成增加和低分子质量HDL尿丢失增加共同解释。